KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $172.36 $172.36 Friday, 22nd Dec 2023 RETA stock ended at $172.36. During the day the stock fluctuated 0% from a day low at $172.36 to a day high of $172.36.
90 days $172.32 $172.46
52 weeks $26.26 $172.46

Historical RETA prices

Date Open High Low Close Volume
Aug 02, 2023 $166.05 $167.24 $165.52 $166.51 704 510
Aug 01, 2023 $165.51 $167.10 $165.35 $166.10 1 287 267
Jul 31, 2023 $165.51 $166.88 $165.08 $165.58 3 289 756
Jul 28, 2023 $164.69 $167.24 $164.25 $167.19 12 323 797
Jul 27, 2023 $106.83 $111.74 $104.79 $108.55 1 377 606
Jul 26, 2023 $106.25 $107.71 $104.61 $106.09 638 158
Jul 25, 2023 $109.88 $111.49 $105.84 $106.48 539 699
Jul 24, 2023 $112.98 $115.23 $109.66 $109.67 351 058
Jul 21, 2023 $110.59 $112.23 $108.84 $110.86 219 671
Jul 20, 2023 $112.91 $113.09 $109.97 $110.11 531 037
Jul 19, 2023 $110.26 $113.61 $108.04 $113.01 580 058
Jul 18, 2023 $111.20 $111.20 $108.04 $109.15 381 582
Jul 17, 2023 $109.40 $111.24 $108.88 $110.47 301 667
Jul 14, 2023 $107.69 $110.37 $107.69 $109.13 346 884
Jul 13, 2023 $109.25 $110.72 $107.18 $107.71 338 243
Jul 12, 2023 $110.00 $110.86 $107.82 $109.04 449 770
Jul 11, 2023 $107.45 $109.99 $104.82 $109.32 570 762
Jul 10, 2023 $104.36 $108.61 $103.60 $107.25 368 087
Jul 07, 2023 $108.00 $108.50 $103.78 $104.37 627 871
Jul 06, 2023 $104.80 $108.00 $103.18 $107.89 683 653
Jul 05, 2023 $102.88 $104.58 $102.27 $103.90 347 677
Jul 03, 2023 $102.00 $103.59 $101.64 $102.88 233 431
Jun 30, 2023 $101.23 $104.59 $99.91 $101.96 693 647
Jun 29, 2023 $100.48 $104.79 $99.45 $100.90 912 118
Jun 28, 2023 $98.03 $103.26 $94.31 $98.83 2 075 904
Click to get the best stock tips daily for free!

About RETA

RETA Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome, as well as for a form of pulmonary arterial hypertension associated ... RETA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT